Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in mice.

Acta Pharm Sin B

Department of Endocrinology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.

Published: December 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725114PMC
http://dx.doi.org/10.1016/j.apsb.2024.10.008DOI Listing

Publication Analysis

Top Keywords

aclysiran rnai
4
rnai therapeutic
4
therapeutic agent
4
agent targeting
4
targeting acly
4
acly treats
4
treats hypercholesterolemia
4
hypercholesterolemia atherosclerosis
4
atherosclerosis mice
4
aclysiran
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!